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Recent studies have demonstrated dramatic shifts in metabolic
supply-and-demand ratios during inflammation, a process result-
ing in localized tissue hypoxia within inflammatory lesions (“in-
flammatory hypoxia”). As part of the adaptive immune response,
T cells are recruited to sites of inflammatory hypoxia. Given the
profound effects of hypoxia on gene regulation, we hypothesized
that T-cell differentiation is controlled by hypoxia. To pursue this
hypothesis, we analyzed the transcriptional consequences of ambi-
ent hypoxia (1% oxygen) on a broad panel of T-cell differentiation
factors. Surprisingly, these studies revealed selective, robust induc-
tion of FoxP3, a key transcriptional regulator for regulatory T cells
(Tregs). Studies of promoter binding or loss- and gain-of-function
implicated hypoxia-inducible factor (HIF)-1α in inducing FoxP3. Sim-
ilarly, hypoxia enhanced Treg abundance in vitro and in vivo. Fi-
nally, Treg-intrinsic HIF-1α was required for optimal Treg function
and Hif1a–deficient Tregs failed to control T-cell–mediated colitis.
These studies demonstrate that hypoxia is an intrinsic molecular
cue that promotes FoxP3 expression, in turn eliciting potent anti-
inflammatory mechanisms to limit tissue damage in conditions of
reduced oxygen availability.
lymphocyte | metabolism | TGF-beta
During inflammation, affected tissues undergo profoundchanges in their metabolic supply-and-demand ratios (1).
This change results from an increased metabolic demand of
resident and infiltrating inflammatory cells, coupled with de-
creased oxygen supply (2). A major consequence of this is a
sharp decline in oxygen availability, resulting in inflammation-
associated hypoxia (i.e., inflammatory hypoxia). Inflammatory
hypoxia is found in multiple pathologies such as inflammatory
bowel disease (IBD), rheumatoid arthritis, or cancer (1, 3, 4).
Hypoxia elicits an orchestrated response in cells, tissues, and
the entire organism to survive a hypoxic challenge (5). On a mo-
lecular level, this response is regulated by oxygen-dependent sta-
bilization of hypoxia-inducible factor (HIF) transcription factors
HIF-1α and HIF-2α (5). In the context of inflammatory disease,
hypoxia has been shown to activate multiple anti-inflammatory
mechanisms (e.g., the generation of extracellular adenosine) that
dampen hypoxia-associated inflammation (1, 6–12). Moreover,
hypoxia-elicited tissue protective mechanisms can be targeted
pharmacologically by using prolyl-hydroxylase (PHD) inhibitors,
which stabilize HIFs and protect against multiple pathologies
including IBD (13, 14). Indeed, a recent study found that PHD
inhibitors can be used safely and efficiently in the treatment of
patients with renal anemia (15).
T cells are frequently recruited to sites of inflammation, where
the resulting response is regulated by multiple cues, including the
local cytokine milieu, interaction with epithelial cells, endothelial
cells, and dendritic cells (16–18). The resulting contribution of
T cells to the propagation or constraint of the inflammatory
response is tightly regulated by the relative abundance of cyto-
kine-producing effector T cells and regulatory T cells (Tregs).
Significantly, defects in recruitment, function, or survival of
Tregs at sites of inflammation result in overexuberant inflamma-
tory responses (19–21).
Given the metabolic changes that occur at sites of inflam-
mation, T cells frequently encounter hypoxia (22, 23). Previous
studies have shown that hypoxia and HIF-1α can regulate mul-
tiple facets of T-cell biology, including development, pro-
liferation, survival, and cytokine production (e.g., IFN-γ), with
Hif1a deficiency associated with overproduction of proinflam-
matory cytokines (24–28). Despite these seminal studies, the full
consequence of hypoxic regulation and HIFs on T-cell differ-
entiation remains an area of intense investigation (22), with re-
cent studies identifying a role for HIF-1α in promoting both
Tregs and Th17 differentiation (29–31).
To gain insights into how T cells are regulated by hypoxia on
a molecular level, we performed a screen to identify which, if
any, transcription factors that direct T-cell differentiation were
hypoxia responsive. This analysis revealed that FoxP3—the key
transcription factor for the differentiation of regulatory T cells—
was robustly induced by hypoxia. Further studies showed that
oxygen availability promotes Tregs through a T-cell intrinsic
HIF-1α pathway, to trigger a Treg-dependent negative feedback
loop to limit the deleterious effects of inflammatory hypoxia.
Results
Hypoxia Selectively Induces FoxP3 Transcription. To study hypoxia
as an environmental cue of the inflamed microenvironment, we
used a T-cell–mediated model of colitis, in which CD45RBhigh
CD4 T cells are adoptively transferred into lymphopenic Rag-
deficient mice (32). As shown in Fig. 1A, mice with active colitis
and robust T-cell infiltration revealed profound hypoxia-probe
staining (green) in the colon, with hypoxia extending into the
submucosal regions. Importantly, we observed the occurrence of
CD3+ T cells (red) within hypoxic lesions, implicating low oxy-
gen levels as an environmental stimulus for infiltrating T cells.
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Consistent with previous studies (1, 3), animals exposed to the
colitis-inducing hapten 2,4,6-trinitrobenzenesulfonic acid (TNBS)
also demonstrated profound extension of hypoxia staining from
the superficial into the submucosal regions, with significant in-
filtration of T cells into these hypoxic microenvironments (Fig.
S1). On the basis of these findings, we next tested the functional
role of ambient hypoxia (1% oxygen for 8 h) on expression of a
panel of transcription factors known to regulate T-cell differen-
tiation. Strikingly, the Foxp3 gene was selectively induced 10-fold
during culture of resting, primary mouse CD4 T cells under
hypoxic conditions (Fig. 1B and Table S1). FOXP3 mRNA was
also transcriptionally induced by hypoxia in human Jurkat cells, in
parallel with a known hypoxia-inducible gene, PGK1 (Fig. 1C),
and corresponding, although modest, changes in FoxP3 protein
(Fig. 1D). Together, these studies indicate selective induction of
FoxP3 during ambient hypoxia.
Hypoxia Stimulates FoxP3 Transcription Through HIF-1α. Early
studies on hypoxia-inducible factor (HIF-1α) in T cells showed
that HIF-1α protein was rapidly stabilized after T-cell receptor
stimulation (33). To assess the relative impact of hypoxia and
T-cell receptor on HIF-1α induction, we used transgenic mice
that ubiquitously express a HIF-luciferase fusion protein (34). In
these mice, the oxygen-dependent degradation domain of HIF-
1α destabilizes luciferase, such that luciferase activity is increased
only in conditions of HIF protein stabilization (such as in hyp-
oxia) (34). When we cultured CD4 T cells from these mice in
hypoxia in the absence of T-cell receptor (TCR) stimulation,
hypoxia induced HIF-luciferase activity relative to normoxia
(Fig. 2A). Whereas TCR stimulation increased HIF-luciferase
activity relative to unstimulated cells in normoxia, hypoxia fur-
ther enhanced the TCR-dependent HIF-luciferase induced in
normoxia (Fig. 2A). Hypoxia also induced HIF-luciferase when
cells were activated through their TCR and given exogenous
TGF-β, a potent cue for Treg differentiation. These data reveal
that hypoxia and TCR activation can function as independent
variables influencing the magnitude of HIF induction and are
consistent with previous studies (33, 35).
Next, we analyzed the transcriptional pathway of FoxP3 in-
duction. Hypoxia elicits a variety of transcriptional changes in
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Fig. 1. Hypoxia specifically activates FoxP3 transcription. (A) To study hyp-
oxia as an environmental cue of the inflamed microenvironment,
CD45RBhigh T-cell–mediated colitis was used as model inflammatory disease.
CD3+ T cells (red) infiltrate into areas of hypoxia (green) during colitis (Left,
lower magnification; Right, higher magnification of white dashed box).
Shown is immunofluorescence on colonic tissue from Rag1-deficient mice
that received 5 × 105 CD45RBhigh CD4 T cells 10 wk prior, with tissue sections
stained with hypoxyprobe (green) and nuclear counter staining with DAPI
(blue). (Scale bar, 100 μm.) (B) qPCR analysis of mRNA expression in primary
mouse CD4 T cells cultured in normoxia or hypoxia for 8 h. (C) Time course of
FOXP3 (white bars) and PGK1 (black bars) mRNA in Jurkat T cells, measured
by qPCR. (D) Flow cytometric analysis of FoxP3 protein in Jurkats exposed to
hypoxia for 27 h (red) relative to normoxia (black) and an isotype control
(gray). All plots show mean ± SEM, are representative of two to four in-
dependent experiments, and include statistical significance calculated by
unpaired t test or ANOVA.
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Fig. 2. Hypoxia stimulates FoxP3 transcription through HIF-1α. (A) Mag-
netically enriched CD4 T cells from ODD-luciferase mice were cultured in
either normoxia or hypoxia for 18 h, with some samples cultured with TCR
stimulation (anti-CD3/CD28 beads), IL-2 ± TGF-β (0.75 ng/mL). Cells were then
harvested and assessed for relative luciferase activity, with data presented as
values standardized to total protein from four independent cultures. (B)
mRNA expression in primary mouse naive CD4 T cells and Tregs relative to b-
actin. (C) Flow cytometric analysis of HIF-1α protein in Jurkat cells in hypoxia
for 6 h (red), in normoxia (black), or stained with an isotype control (gray).
(D) Treatment of Jurkat cells with AKB-6899 (100 μM) for 1 h in normoxia
induces FoxP3, measured by qPCR. (E) The human FOXP3 promoter is acti-
vated during hypoxia. Data show relative luciferase activity in Jurkat cells
transfected either with empty pGL4.17 plasmid (left) or with a plasmid
containing 900 bp of the proximal FOXP3 promoter (right), with cells cul-
tured in normoxia (Nx) or hypoxia (Hyp) for 24 h posttransfection. Data show
mean ± SEM from three independent experiments. (F) The human FOXP3
gene has many predicted HREs, shown as vertical lines (asterisks indicate sites
without obvious conservation in the mouse). (G and H) HIF-1α protein binds
directly to the FOXP3 promoter in Jurkat T cells cultured in hypoxia for 6 h,
measured by ChIP followed by qPCR (G) or by gel electrophoresis (H), with
primers designed to amplify the indicated HRE (location relative to TSS, see
schematic). HIF-1α protein binding to the PGK1 promoter is a positive con-
trol. (I) Lentiviral knockdown of HIF-1α in Jurkat cells, showing HIF1A mRNA
levels in control (white) or HIF-1α knockdown (black) Jurkats, measured by
qPCR. (J) Percentage of change in FOXP3 mRNA in control (white) or HIF-1α
knockdown (black) Jurkats relative to normoxia, measured by qPCR. Data in
A depict mean ± SEM for four replicate cultures, from two independent
experiments with statistical significance calculated by unpaired t test (com-
paring normoxia vs. hypoxia). All plots show mean ± SEM, are representative
of two to three independent experiments, and include statistical significance
calculated by unpaired t test.
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cells, with HIF-1α and HIF-2α as two primary transcriptional
mediators that regulate transcription through heterodimerization
with HIF-1β and binding to hypoxia response elements (HREs) in
a target gene (5). Within the FoxP3 gene, we identified multiple
candidate HREs (defined as RCGTG), raising the possibility
that FoxP3 is directly regulated byHIF.Given that our studies with
the HIF-luciferase mice do not discriminate between oxygen-
dependent regulation of HIF-1α and that of HIF-2α, we next
measured the relative abundance of HIF-1α and HIF-2α in naive
CD4 T cells and in Tregs. These studies revealed higher mRNA
levels of HIF-1α than of HIF-2α in naive CD4 T cells (Fig. 2B) and
almost complete repression of HIF-2α upon differentiation of
a naive CD4 T-cell to a Treg. We therefore focused on HIF-1α,
which was stabilized during hypoxic culture of Jurkat cells, a hu-
man T-cell line, before FoxP3 transcriptional induction (Fig. 2C).
Hypoxia stabilizes HIF-1α protein by inhibiting PHDs,
enzymes that promote HIF-1α degradation in normoxia. HIF-1α
can also be stabilized by pharmacological PHD inhibitors (8, 36,
37). To test whether HIF-1α stabilization by PHD inhibition was
sufficient to transcriptionally induce FoxP3, we treated cells with
the PHD inhibitor AKB-6899 and observed induction of FoxP3
mRNA. These data are consistent with direct HIF-1α activation
of FoxP3 transcription independent of other hypoxia-elicited
changes (Fig. 2D).
FoxP3 is subject to multiple levels of regulation. To test
whether the FoxP3 promoter is itself responsive to hypoxia, we
tested the ability of the FoxP3 promoter to be activated during
hypoxia. Following transfection of a luciferase construct con-
taining the human FOXP3 promoter into Jurkats, we observed
that hypoxia increased luciferase activity, indicating that the
FOXP3 promoter itself is hypoxia responsive (Fig. 2E). To de-
termine whether FoxP3 was a direct transcriptional target of
HIF-1α, we performed a chromatin immunoprecipitation (ChIP)
analysis. Given the complex transcriptional regulation of FoxP3
(38), we performed ChIP for HIF-1α binding at 14 of the 19 pu-
tative HREs in the human FOXP3 locus. Among the 4 HREs in
the human FOXP3 gene with positional orthologs in the mouse
(Fig. 2F), we identified specific HIF-1α protein binding to a single
consensus HRE located 819 bp 5′ of the transcriptional start site
(TSS) (39) (Fig. 2 F and G). Specific HIF-1α binding to the
FOXP3 HRE at −819 was further confirmed by agarose gel
electrophoresis (Fig. 2H). Finally we tested the requirement for
HIF-1α on FoxP3 induction by RNA interference. Stable knock-
down of HIF-1α significantly impaired HIF-1α levels and the
hypoxic induction of FoxP3 in Jurkats (Fig. 2 I and J). We noted
a modest FoxP3 induction in this experiment, relative to that in
Fig. 1C, that may be a result of culture selection posttransduction.
In total, these data identify FoxP3 as a direct HIF-1α target gene.
Hypoxia Enhances the Relative Abundance of Tregs After in Vitro
Activation. Hypoxic stimulation of FoxP3 mRNA suggested that
hypoxia may enhance Treg abundance. To test this, we first an-
alyzed Treg abundance by activating primary, murine T cells in
bulk, unpurified splenocyte cultures under either normoxic or
hypoxic conditions (1% ambient hypoxia). As anticipated, hyp-
oxia increased the percentage of FoxP3+ cells after in vitro
stimulation; this hypoxic enhancing effect occurred in cultures
activated using either neutral (soluble anti-CD3 + IL-2) (Fig.
3A) or Treg-inducing (soluble anti-CD3 + IL-2 + TGF-β) con-
ditions (Fig. 3B). Tregs elicited by hypoxic culture expressed
multiple proteins characteristic of Tregs (Fig. 3C).
One caveat to studies using bulk, unpurified splenocytes is that
hypoxia may have both direct and indirect effects on CD4 T cells.
To directly investigate the effects of hypoxia on the de novo gen-
eration of FoxP3-expressing cells, we sorted naive CD4+FoxP3−
cells (defined as CD4+CD62LhiCD44lowCD25−FoxP3GFP−), us-
ing FoxP3-GFP reporter mice (40). In parallel, we also isolated
existing Tregs (defined as CD4+ FoxP3GFP+ cells) (Fig. 3D).
IsolatedT cells were then subjected to in vitro stimulation in either
normoxia or hypoxia.This analysis revealed that hypoxia enhanced
the relative proportion of de novo-generated FoxP3+ T cells in
vitro, while having little effect on the relative proportion of pre-
existing Tregs (Fig. 3 E and F). These data indicate that hypoxia
increases the relative abundance of inducible Tregs during in vitro
activation and differentiation of primary, naive CD4 T cells. In
total, the above studies demonstrate that hypoxic culture is uni-
formly associated with a relative increase of FoxP3+ events among
CD4+ T cells and that hypoxia can mediate this effect by directly
regulating CD4 T cells.
Hypoxia Influences Proliferation and the Relative Abundance of Tregs
After in Vitro Culture.Hypoxia is known to influence rates of both
proliferation and survival (22, 26), and hypoxic cultures routinely
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Fig. 3. Hypoxia enhances the relative abundance of Tregs after in vitro
activation. (A) Hypoxia enhances the frequency of FoxP3+ CD4 T cells after in
vitro stimulation of primary mouse CD4 T cells with soluble anti-CD3 anti-
body (1 μg/mL) in bulk splenocyte culture, comparing cells cultured in nor-
moxia (Nx, white bar) or hypoxia (Hyp, black bar). (B) Hypoxia enhances the
frequency of FoxP3+ CD4 T cells after in vitro stimulation of primary mouse
CD4 T cells with soluble anti-CD3 antibody (1 μg/mL), IL-2, and TGF-β1 in bulk
splenocyte culture, comparing cells cultured in normoxia (Nx, white bar) or
hypoxia (Hyp, black bar). (C) Flow cytometric analysis of protein expression
within FoxP3+ CD4 T cells after 3 d of stimulation in hypoxia (red line) or
normoxia (gray shading). (D) Experimental scheme to test the effect of
hypoxia on the induction of FoxP3 expression in different T-cell subsets
(Tregs vs. non-Tregs). (E and F) Hypoxia enhances de novo FoxP3 expression
in non-Tregs (E), while having no effect on the relative abundance of
existing Tregs (F). CD4 T cells fom FoxP3-GFP mice were sorted either as
CD25-negative Foxp3GFP-negative (non-Tregs) or Foxp3GFP-positive cells
(Tregs) and then stimulated with anti-CD3/CD28 microbeads and IL-2 for 3–
5 d in either normoxia or hypoxia. Viable CD4 T cells were then analyzed for
expression FoxP3 GFP by flow cytometry, with data depicting mean ± SEM
for three to six replicate cultures, from two independent experiments. (G
and H) Absolute cell counts for either Tregs (G) or non-Tregs (H) following
stimulation of naive CD4, FoxP3− cells isolated from FoxP3GFP mice with
anti-CD3/CD28 microbeads and IL-2 for 3 d in either normoxia or hypoxia.
CD4 T cells were defined as viable, MHC class II negative, CD4+ events by flow
cytometry, which were either FoxP3+ (Tregs, in G) or FoxP3− (non-Tregs, in
H), with data depicting mean ± SEM for nine replicate cultures, from two
independent experiments. All plots show mean ± SEM representative of two
to four independent experiments, with flow cytometric results from a mini-
mum of triplicate cultures (A and B), and include statistical significance cal-
culated by unpaired t test.
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had reduced cellularity relative to normoxic cultures. Despite the
increased frequency of de novo Tregs following hypoxic culture
(Fig. 3E), when we calculated total cellularity for both Tregs and
non-Tregs, we found that hypoxic cultures had Treg numbers
that were relatively comparable to levels observed in normoxia
(Fig. 3G). In contrast, hypoxic cultures had a reduced number of
non-Tregs (defined as CD4+ FoxP3− cells) (Fig. 3H). Similar
deficits in non-Treg abundance following hypoxic culture were
also observed, using total splenocytes stimulated with soluble
anti-CD3, IL-2, and TGF-β (Fig. S2). The reduction in cellularity
and non-Tregs under hypoxic conditions may result from re-
duced proliferation in hypoxia, especially among non-Tregs (Fig.
S2). On the basis of these data, in vitro cultures of activated
T cells under hypoxic conditions are associated with a relative
sparing of Tregs compared with non-Tregs, in turn resulting in an
increased percentage of FoxP3+ cells among CD4 T cells. These
results indicate that in vitro culture of activated T cells under
hypoxic conditions enhances the proportion of Tregs relative
to non-Tregs.
Hypoxia Enhances the Relative Treg Abundance in Vitro by a TGF-
β–Dependent Mechanism. FoxP3 expression is known to be regu-
lated by multiple factors, including TCR signaling, costimulation,
NF-κB, and TGF-β (41). When we examined expression of cos-
timulatory proteins (CD28 and its negatively regulating coun-
terpart CTLA-4) and the NF-κB family member c-Rel, we found
that hypoxic cultures had comparable expression levels relative
to normoxic cultures (Fig. 4A). On the basis of these expression
levels, hypoxic induction of FoxP3 does not appear to be due to
alterations in costimulatory molecules or through enhanced ex-
pression of c-Rel.
Previous studies have shown a central role for TGF-β as a
regulator for FoxP3 (42). The fact that TGF-β is a known HIF
target gene introduces the possibility that hypoxia induction of
Tregs involves a coordinated response involving HIF and TGF-β
(43, 44). To test the role of TGF-β in the hypoxic induction of
FoxP3-expressing cells, we used FoxP3 GFP reporter mice, in
which GFP expression is directed by an internal ribosome entry
site inserted within the endogenous Foxp3 locus, such that GFP
expression corresponds directly to FoxP3 mRNA abundance
(40). Following culture, we measured both GFP expression (as
a measure of FoxP3 mRNA) and endogenous FoxP3 protein.
Notably, TGF-β neutralization significantly attenuated hypoxia-
dependent enhancement of both FoxP3 mRNA-expressing cells
(measured by GFP expression) and FoxP3 protein-expressing
cells following in vitro T-cell activation (Fig. 4 B and C). To-
gether, these studies indicate that the in vitro hypoxic enhance-
ment of Tregs requires TGF-β signaling for full hypoxic
induction of FoxP3 mRNA and protein following T-cell activa-
tion and differentiation.
Hypoxia Enhances the Relative Abundance of Tregs in the Presence of
IL-1 but Not IL-6. Given the frequent overlap of inflammation and
hypoxia, we tested whether the hypoxic enhancement of Tregs
also occurred in the context of the inflammatory cytokines IL-6
and IL-1. When anti-CD3–stimulated bulk splenocytes were
cultured with TGF-β, hypoxia enhanced the proportion of Tregs
in culture (Fig. 4 D and E). Addition of increasing amounts of
IL-6, a known antagonist of FoxP3 expression (45, 46), pre-
cipitously decreased the relative abundance of Tregs in both
normoxia and hypoxia, such that the hypoxic enhancement of
Treg abundance was lost with addition of IL-6 (Fig. 4D). In
contrast, increasing amounts of IL-1 resulted in a modest re-
duction in the overall percentage of Tregs present in normoxia
(Fig. 4E). Notably, hypoxic cultures retained a relative increase
in the percentage of FoxP3+ T cells in the presence of IL-1 (Fig.
4E). In total, these data indicate that T-cell activation under
hypoxic conditions can enhance the relative abundance of Tregs
not only under neutral and Treg-promoting conditions, but also
under select inflammatory conditions, dependent on the specific
inflammatory milieu.
Hypoxia Is Not Sufficient to Induce de Novo Th17 Differentiation in
the Absence of Th17 Differentiation Cues. Recent studies have
shown that HIF-1α is critical for Th17 differentiation in vitro and
in vivo (30, 31). To test the impact of hypoxia on Th17 differ-
entiation, relative to its effect on enhancing Treg abundance, we
analyzed in vitro Treg and Th17 differentiation under normoxic
and hypoxic conditions. When T cells were cultured under Treg
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Fig. 4. Hypoxia enhances the relative abundance of Tregs in vitro by a TGF-
β–dependent mechanism. (A) Flow cytometric analysis of CD28, CTLA-4 (cell
surface) within viable CD4 FoxP3+ T cells, or c-Rel within viable CD4 T cells
following culture for 3–5 d in either normoxia (black line with gray shading)
or hypoxia (red line). Analysis of c-Rel includes an isotype control stain (dark
gray). Results are representative of three independent experiments. (B and
C) Hypoxic induction of FoxP3 mRNA and protein in vitro is TGF-β de-
pendent. Sorted naive, FoxP3− CD4 T cells from FoxP3-GFP mice were stim-
ulated in normoxia (white bars) or hypoxia (black or gray bars) for 3 d, with
or without a blocking TGF-β antibody (αTGF-β, 10 μg/mL). Relative abun-
dance of FoxP3 expression was measured by GFP fluorescence (B, where GFP
expression is under control of an internal ribosome entry site linked to the
FoxP3 gene) or by antibody detection of FoxP3 protein by flow cytometry
(C). Data depict the percentage of CD4+ events that are either GFP+ (B) or
FoxP3+ (C), where all CD4 T cells were pregated on viable, MHC class II
negative events. (D and E) Hypoxic enhancement of Tregs by TGF-β and the
effect of inflammatory cytokines on this induction. Bulk splenocytes were
cultured with soluble anti-CD3 antibody (1 μg/mL), IL-2 (10 ng/mL), and TGF-
β1 (0.75 ng/mL), with or without a series of dilutions of either IL-6 (G) or IL-1
(H). The frequency of FoxP3+ events among CD4+ T cells was measured by
flow cytometry after 3 d of stimulation in hypoxia (Hyp) or normoxia (Nx).
All plots show mean ± SEM representative of two to three independent
experiments, with flow cytometric results from triplicate cultures (B–E), and
include statistical significance calculated by unpaired t test or ANOVA.
Clambey et al. PNAS | Published online September 17, 2012 | E2787
IM
M
U
N
O
LO
G
Y
PN
A
S
PL
U
S
D
ow
nl
oa
de
d 
at
 T
HE
 L
IB
RA
RY
 (#
18
57
23
75
) o
n M
arc
h 1
0, 
20
20
 
differentiation conditions (IL-2, TGF-β), we found that hypoxia
enhanced the differentiation of Tregs (Fig. 5A). In contrast, hypoxia
had neglible effects on the induction of Th17 cells under Treg dif-
ferentiation conditions (Fig. 5B). Consistent with a failure of hypoxia
to induce Th17 differentiation using Treg differentiation conditions,
hypoxia did not influence the expression of RORγ, a critical Th17
transcription factor, following hypoxic culture (Fig. 5C).
Hypoxia Enhances Th17 Differentiation in the Presence of Th17
Differentiation Cues. Whereas Th17 differentiation was not en-
hanced under Treg differentiation conditions, we next tested
what consequence hypoxia had on Th17 differentiation in the
presence of Th17 differentiating cytokines (TGF-β and IL-6, plus
antibodies against IFN-γ and IL-4). When T cells were cultured
in hypoxia under Th17 differentiation conditions, we found that
hypoxia enhanced the differentiation of Th17 cells (Fig. 5D). In
these same conditions, hypoxia neither significantly enhanced
nor repressed the relative abundance of Tregs (Fig. 5E). These
data indicate that hypoxia can enhance Th17 differentiation,
given the presence of optimal Th17 differentiation cytokines.
Hypoxia Does Not Result in FoxP3 Protein Degradation Under Treg
Differentiation Conditions. In addition to showing data that HIF-
1α is important for Th17 differentiation, Dang et al. showed that
HIF-1α may actually reduce FoxP3 expression through protea-
somal degradation (31). Although we had not routinely seen an
overall reduction in FoxP3 protein expression on an individual
cell basis (Fig. 3C), we tested whether hypoxia might result in
a significant discordance in the frequency of FoxP3 mRNA-
expressing cells relative to FoxP3 protein-expressing cells. To do
this, we again made use of FoxP3 GFP reporter mice, in which
GFP serves as a transcriptional reporter for FoxP3 mRNA (40).
In these mice, GFP expression serves as a transcriptional re-
porter of FoxP3 mRNA, given the placement of the GFP gene
downstream of an internal ribosomal entry site within the en-
dogenous Foxp3 locus. Next, we measured the frequency of GFP-
expressing cells (i.e., FoxP3 mRNA-expressing cells from the
FoxP3-GFP reporter mice) relative to the frequency of FoxP3
protein-expressing cells, by direct detection of FoxP3 protein
(Fig. 5F). There was a tight correlation between the frequency of
GFP+ and FoxP3+ cells in both normoxia and hypoxia (Fig. 5G),
indicating that almost all cells that expressed FoxP3 mRNA
(detected here by GFP) also expressed FoxP3 protein. In addition,
the relative expression levels of GFP and FoxP3 protein on a per
cell basis were similar between normoxia and hypoxia. The strong
correlation between a transcriptional reporter and the endogenous
protein, in combination with the normal FoxP3 expression in
ROR
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Fig. 5. Hypoxia induces Tregs, not Th17 cells, under Treg differentiation conditions. (A and B) Hypoxia enhances the frequency of FoxP3+ CD4 T cells after in
vitro stimulation of CD4 T cells in bulk splenocyte culture, with soluble anti-CD3 antibody (1 μg/mL), IL-2, and TGF-β1, comparing cells cultured in normoxia
(Nx, white bar) or hypoxia (Hyp, black bar). Total splenocytes were cultured in normoxia (white bar) or hypoxia (black bar), using Treg differentiation
conditions for 5 d, at which time cells were restimulated with PMA, ionomycin, and monensin for 5 h. Cells were then stained for FoxP3 and IL-17A expression,
with data depicting the percentage of viable, activated CD4 T cells that express either FoxP3 (A) or IL-17A (B). (C) Flow cytometric analysis of RORγ expression
within viable CD4 T cells, comparing relative expression in normoxic (black line) or hypoxic (red line) cultures relative to an isotype control stain (gray area).
Results are representative of two independent experiments. (D and E) Hypoxia enhances differentiation of IL-17A+ cells after in vitro stimulation of CD4 T cells
in bulk splenocyte culture, containing Th17-inducing conditions. Total splenocytes were cultured in normoxia (white bar) or hypoxia (black bar) under Th17
differentiation conditions for 5 d, at which time cells were restimulated with PMA, ionomycin, and monensin for 5 h. Cells were then stained for FoxP3 and IL-
17A expression, with data depicting the percentage of viable, activated CD4 T cells that express either IL-17A (D) or FoxP3 (E). (F) Flow cytometric analysis of
FoxP3 protein expression (Upper) or GFP expression (Lower) (a transcriptional reporter for FoxP3 expression) from FoxP3-GFP cells, following 5 d of stimu-
lation in hypoxia (red line) or normoxia (gray area). (G) Ratio comparing the frequency of FoxP3 protein-expressing cells relative to the frequency of GFP-
positive cells, using FoxP3-GFP transcriptional reporter mice, based on flow cytometric data as shown in F. Results are representative of two independent
experiments. In A, B, and D, data depict mean ± SEM for four to six replicate cultures from two independent experiments and include statistical significance
calculated by unpaired t test (comparing normoxia vs. hypoxia).
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hypoxia (Fig. 3F), argues that hypoxia per se is not sufficient to
induce proteasomal degradation of FoxP3 protein (31).
Hypoxia and HIF Signaling Enhance Treg Abundance in Vivo. To ex-
amine the role of tissue hypoxia on FoxP3 induction and Treg
abundance in vivo, we first used murine whole-body hypoxia. As
predicted from our in vitro studies, we observed an increased
percentage of Tregs in hypoxia-treated animals (Fig. 6A) (10%
oxygen for 24 h). These Tregs had comparable protein expres-
sion profiles to those of Tregs in control mice (Fig. 6B). Next, we
examined the consequence of pharmacologic HIF-1α stabiliza-
tion on Treg abundance in vivo. Mice treated with a PHD in-
hibitor had increased FoxP3 mRNA in the thymus, although
FoxP3 mRNA was not increased in the spleen (Fig. 6C and Fig.
S3). These data indicate that whole-body hypoxia or pharma-
cologic HIF-1α stabilization can enhance FoxP3 expression and
Treg abundance in vivo.
T-Cell Intrinsic HIF-1α Is Required for Optimal Treg Suppressive
Function. Whereas our studies to this point focused on the con-
tribution of hypoxia on Tregs, we next sought to test the genetic
contribution of T-cell–intrinsic HIF-1α within Tregs. To do this,
we isolated Tregs from mice containing a specific deletion of
Hif1a (Hif1a flox/flox LckCre mice) and compared them to
control Tregs. Hif1a–deficient animals had comparable numbers
of Tregs to those of their littermate controls and Tregs isolated
from these animals were of equivalent purity, with comparable
protein expression among common Treg markers (Fig. S4).
First, we tested the suppressive capacity of Hif1a-deficient
Tregs under conditions of normoxia and hypoxia, by using a well-
established in vitro suppression assay for Treg function. When
we tested the relative ability of Hif1a-deficient Tregs to limit
proliferation of violet trace-labeled CD4 T cells, we found that
Hif1a-deficient Tregs had a significant defect in their suppressive
function (Fig. 7 A and B). This deficit in suppressive activity of
Hif1a–deficient Tregs was observed in conditions of robust T-cell
proliferation (normoxia); in contrast, Hif1a–deficient Tregs were
able to mediate more modest suppressive effects required to
limit reduced effector T-cell proliferation in conditions of hyp-
oxia (Fig. S4). These data indicate that HIF-1α plays a critical
role in promoting optimal suppressive function of Tregs in vitro.
HIF-1α Is Required Within Tregs to Suppress T-Cell–Mediated Colitis.
Given the potential role of HIF-1α in regulating both effector T-
cell and regulatory T-cell function, we next tested the Treg-in-
trinsic requirement for HIF-1α for limiting inflammation in vivo.
To do this, we used the CD4 T-cell CD45RBhigh adoptive
transfer model of colitis into Rag1-deficient mice, a model pre-
viously shown to be driven by pathogenic effector T cells (32),
and a disease process that can be controlled by the adoptive
transfer of regulatory T cells (47). To specifically isolate the
genetic contribution of HIF-1α only to Tregs, control (Hif1a F/F)
Tregs or Hif1a–deficient (Hif1a F/F LckCre) Tregs were
cotransferred with wild-type CD45RBhigh CD4 T cells at a phys-
iologically relevant 1:4 ratio of Treg:CD45RBhigh CD4 T cells.
Whereas control Tregs limited onset of colitis, as revealed by
protection against weight loss (Fig. 7C), protection against colon
shortening (Fig. 7D), and protection against histological damage
(Fig. 7 E–I), mice receiving Hif1a–deficient Tregs failed to limit
colitis as evidenced by failure to protect against weight less,
decreased colon lengths, and a trend toward worse histological
damage. In total, these data indicate that Treg-intrinsic HIF-1α
is required for optimal Treg suppressive function in vivo, par-
ticularly in the context of inflammatory bowel disease.
Discussion
Hypoxia is a common occurrence in a variety of inflammatory
and pathological conditions and has long been appreciated to
induce adaptive responses at the cellular, tissue, and organismal
levels (1, 5). These hypoxia-elicited changes in gene expression
elicit adaptive responses that promote adaptation to limited
oxygen availability. Particularly during inflammatory hypoxia,
HIF-dependent transcription can activate multiple anti-inflam-
matory mechanisms (13, 14, 22, 48). One notable example of this
is the coordinated induction of the extracellular adenosine path-
way (7), a pathway that in the context of T cells can both promote
Treg differentiation and function as a Treg effector mechanism
(9, 49). Here, we hypothesized that hypoxia-elicited transcription
could directly influence T-cell differentiation and function. To test
this, we screened key transcription factors for T-cell differentia-
tion and observed a selective and robust induction of FoxP3 with
hypoxia. We further present data that FoxP3 is a direct HIF-1α
target gene, that hypoxia through HIF-1α promotes the abun-
dance and function of Tregs in vitro and in vivo, and that Treg-
intrinsic HIF-1α is critical in constraining inflammation. In total,
our data indicate this pathway is important in limiting tissue in-
flammation during inflammatory hypoxia, particularly during in-
testinal inflammation.
The molecular regulation of FoxP3 is coordinated through
multiple levels of positive and negative regulation. Although
FoxP3 expression is enhanced by costimulatory molecules (e.g.,
CD28) and TGF-β (42, 50), expression can be restricted by
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Fig. 6. Hypoxia and HIF signaling enhance Treg abundance in vivo. (A) Whole-body hypoxia (10% O2) increases Treg abundance in the spleen after 24 h. Data
show mean ± SEM, indicating percentage of live CD4 T cells that are FoxP3+, n = 4–5 mice per group, with data representative of two independent
experiments and analyzed by unpaired t test. (B) Phenotype of Tregs after whole-body hypoxia, with histogram overlays comparing protein expression in
Tregs in 21% (gray) or 10% O2 availability (black). (C) Treatment of mice with a PHD inhibitor increases FoxP3 mRNA expression in the thymus, measured by
qPCR in thymus, in B6 mice treated with vehicle (control) or with AKB-4924. Data show mean ± SEM, n = 5 mice per group, representative of two independent
experiments. Statistically significant differences are indicated, calculated by unpaired t test.
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methylation and by strong T-cell receptor signaling that activates
the PI3 kinase pathway (41, 51, 52). Significantly, these distinct
developmental and microenvironmental cues coordinate Foxp3
expression through multiple, conserved transcriptional elements
in the Foxp3 locus, work elegantly revealed through targeted
deletion of individual, conserved enhancer elements (38). Within
this larger context, our data indicate that hypoxia promotes
FoxP3 and regulatory T-cell function through at least three dis-
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Fig. 7. Treg-intrinsic HIF-1α is required for optimal Treg suppressive function in vitro and in vivo. (A and B) HIF-1α is required for optimal suppressive function
of regulatory T cells in normoxia. Shown is in vitro Treg suppression assay using different ratios of CD4+ CD25+ T cells from Hif1a flox/flox (F/F) or Hif1a flox/
flox LckCre+ mice cocultured with Violet Trace-labeled CD4+ CD25− T cells from Hif1a flox/flox mice, irradiated APCs, and soluble anti-CD3 (1 μg/mL). T-cell
proliferation was assessed 4 d poststimulation, with data obtained from four independent cultures, with cells isolated from two independent mice. Data
depict (A) the percentage of CD4+ CD25− T cells that have undergone at least one round of division, showing mean ± SEM for four independent cultures, and
(B) proliferation of CD4+ CD25− T cells as measured by Violet Trace dilution at multiple different ratios of effector T cells to regulatory T cells, with control
Treg cultures plotted in black (upper) and Hif1a–deficient Treg cultures plotted in red (lower). Statistically significant differences are indicated, calculated by
unpaired t test. (C–I) Rag1−/− mice were adoptively transferred with CD4+ CD45RBhigh cells with or without CD4+ CD25+ Tregs from control mice or mice
deficient in Hif1a in T cells (Hif1a F/F LckCre). Progression to colitis was monitored weekly by weight loss (C) or at the time of harvest by measuring colon
length (D) or by histological scoring (E). Examples of histology in each of the groups are provided in F–I, corresponding to mice without T-cell transfer (F) or
receiving CD45RBhigh cells without Tregs (G), CD45RBhigh cells + control Tregs (H), or CD45RBhigh cells + Hif1a–deficient Tregs (I). Data indicate mean ± SEM (n =
9–13 mice per group), from three independent experiments except for E, which shows data from n = 4–8 mice per group from two independent experiments.
For Hif1a genotype, F refers to floxed. (Scale bars in F–I, 200 μm.) Statistically significant differences are indicated, calculated by unpaired t test or by ANOVA
with Tukey’s posttest correction.
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tinct mechanisms: (i) direct transcriptional activation of FoxP3
mRNA by HIF-1α early after hypoxia, (ii) a hypoxia-driven, TGF-
β–dependent process required for full hypoxic induction of FoxP3
mRNA and protein following T-cell activation and differentia-
tion, and (iii) a Treg-intrinsic role for HIF-1α that is required for
optimal suppressive function of Tregs in vitro and in vivo. Given
the inhibitory effects of hypoxia on proliferation and survival,
hypoxia is also associated with an enhanced relative abundance
of Tregs in comparison with non-Tregs; we have observed the
enhanced relative abundance of FoxP3+ cells under hypoxic
conditions both in vitro and in vivo, demonstrating that hypoxia
generally enhances the relative abundance of Tregs. In this con-
text, it is possible that hypoxic microenvironments arising during
inflammation may function as foci that trigger a cascade of in-
hibitory mechanisms, characterized by an increased ratio of in-
hibitory to effector T cells and the activation of additional anti-
inflammatory pathways, such as the generation of extracellular
adenosine, an inhibitory mechanism used by Tregs (1, 7, 9). The
multilayer impact of hypoxia and HIF-1α on Tregs, in both hyp-
oxia and normoxia, is consistent with previous reports demon-
strating the role of hypoxia on T-cell function and of HIF-1α–
dependent regulation of T cells in both hypoxia and normoxia
(22, 30, 31).
Early studies of HIF-1α in T cells led to the concept that
a primary function of hypoxia and HIF-1α in T cells is to con-
strain T-cell–mediated inflammation, a concept pioneered by
Sitkovsky (28, 53). Since then, the role of HIF-1α in T-cell dif-
ferentiation has been the subject of increasing investigation, with
different groups finding divergent roles for HIF-1α. Our data,
demonstrating that hypoxia, via HIF-1α, promotes regulatory T
cells is consistent with a previous report by Ben-Shoshan et al., in
which they identified HIF-1α–dependent hypoxic induction of
FoxP3 in Jurkat T cells (29). The authors showed that hypoxia
increased FoxP3 expression in mouse splenocytes and human
peripheral blood mononuclear cells and that transfection of
HIF-1α in mouse cells resulted in increased FoxP3 expression in
vitro and in vivo (29). Although this paper identified hypoxic
induction of FoxP3-expressing cells, the in vivo significance of
this pathway, in terms of both pharmacologic manipulation and
loss-of-function, was unknown. Our study has further in-
vestigated the hypoxic regulation of FoxP3, to demonstrate that
HIF-1α binds directly to the FOXP3 promoter, that hypoxic in-
duction of FoxP3 requires both HIF-1α and TGF-β, and that loss
of Hif1a within Tregs results in a Treg-intrinsic deficit in con-
trolling intestinal inflammation. Whereas Hif1a–deficient Tregs
are not completely devoid of suppressive function, our in vitro
and in vivo studies demonstrate that HIF-1α within Tregs is re-
quired for optimal Treg function. These observations are im-
portant because they provide genetic evidence that HIF-1α has
a Treg-intrinsic role in limiting inflammation. Beyond this study,
it is intriguing to note that recent data describing a hypomorphic
FoxP3 allele (encoded by a FoxP3-GFP fusion protein) demon-
strated that this fusion protein had a reduced interaction with
HIF-1α, an enhanced interaction with IRF4, and selective defi-
cits in Treg function (54).
In contrast to data indicating that hypoxia and HIF-1α pro-
mote Tregs, two papers recently reported that HIF-1α is essen-
tial for the generation of proinflammatory Th17 cells in vitro and
in vivo (30, 31). Further, the authors concluded that HIF-1α
promotes Th17 differentiation and limits Treg differentiation,
identifying HIF-1α as a central regulator of the Treg/Th17 bal-
ance. This conclusion was based on the observation that deletion
of Hif1a impaired Th17 differentiation while enhancing gener-
ation of Tregs (30, 31). Although the precise molecular basis for
this observation was different between the two papers, both
groups showed that HIF-1α was required for induction of ex-
perimental autoimmune encephalitis, a Th17-driven model of
autoimmunity in vivo.
In the study by Shi et al., the authors focused on how T-cell
differentiation and glycolysis were regulated under normoxic
conditions (30). First, they demonstrated that in vitro Th17 dif-
ferentiation was associated with HIF-1α–dependent induction of
glycolytic activity. The authors then showed that Hif1a–deficient
T cells were impaired in becoming Th17 cells in vitro and in vivo
and instead were more efficient at becoming Tregs in Th17-in-
ducing conditions. This altered differentiation appeared to result
from increased FoxP3 expression coupled with impaired ex-
pression of the IL-23 receptor, a cytokine receptor important for
expansion and survival of Th17 cells (30, 55). Importantly, these
studies were uniformly done in the context of normoxia. In
contrast to their findings, we did not observe an increase of
normoxic FoxP3 levels in Hif1a–deficient Tregs. Consistent with
previous studies, we found that HIF-1α increases FoxP3 mRNA
and Treg abundance.
The role of HIF-1α in Th17 differentiation was also the focus
of a study by Dang et al. In this paper, the authors show that
HIF-1α influences the Th17/Treg balance (i) by the induction of
RORγt and subsequent transactivation of Th17-associated
genes, (ii) while limiting FoxP3 protein through HIF-1α–medi-
ated protein degradation (31). Beyond showing that HIF-1α is
necessary and sufficient for Th17 differentiation in vitro, the
authors also showed that hypoxia, which will induce HIF-1α,
enhanced Th17 differentiation, while decreasing FoxP3 protein
through a proteasome-dependent mechanism of degradation.
To understand the apparent differences between our study
and those above showing a critical role for HIF-1α in Th17 cells,
we tested the role of hypoxia on the generation of Tregs and
Th17 cells. Consistent with Dang et al., we found that culturing
T cells in Th17-inducing conditions in hypoxia enhances Th17
cell generation. However, when we cultured T cells in Treg-in-
ducing culture conditions, we found that hypoxia is completely
unable to induce Th17 differentiation and instead enhances
Treg differentiation. Also, in contrast to Dang et al., we found
no evidence of reduced FoxP3 protein within Tregs cultured in
hypoxia, using a state-of-the-art reporter mouse that allows us to
investigate mRNA and protein expression analyses by flow
cytometry. Previous studies had shown that hypoxia—as occurs
during conditions of intestinal inflammation (1)—induces TGF-
β (43), thereby setting up a microenviroment that strongly favors
Treg differentiation. Indeed, although HIF-1α may play
a prominent role in Th17-mediated autoimmune diseases (such
as experimental autoimmune encephalitis) (30, 31), when we
directly tested the role of Treg-intrinsic Hif1a in vivo, we found
that Hif1a–deficient Tregs fail to limit T-cell–mediated colitis,
demonstrating that HIF-1α plays a Treg-intrinsic role in limiting
inflammation.
Although Th17 cells may use HIF-1α to promote their meta-
bolic and differentiation requirements, it is important to note
that Th17 cells are not unique in their expression of HIF-1α.
Early studies by Lukashev et al. clearly demonstrated that HIF-
1α protein is stabilized following T-cell receptor engagement
(33), results we have corroborated here. In addition, although
Dang et al. found that Th17 cells had the highest levels of HIF-
1α mRNA, inducible Tregs also had elevated levels of HIF-1α
relative to naive CD4 T cells, levels much higher than in either
Th1 cells or Th2 cells (31). Furthermore, TGF-β treatment of
activated CD4 T cells stabilized HIF-1α protein, albeit to a lesser
extent than that observed in Th17 culture conditions (31).
Whereas HIF-1α may facilitate divergent outcomes of differ-
entiation, recent studies on HIF-1α in T cells have surprisingly
overlooked hypoxia-induced TGF-β signaling as a common
mechanism underlying the effects of hypoxia on CD4 T cells.
TGF-β is known to be a downstream effector of hypoxia: TGF-β
is induced at the mRNA level in hypoxia, and the mature TGF-β
protein is induced through posttranslational mechanisms, in-
cluding hypoxic induction of furin mRNA and furin protein
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relocalization to the cell membrane to cleave cell surface-bound
TGF-β (43, 44, 56). Further, TGF-β itself can enhance HIF-1α
expression through inhibition of PHD2, a critical negative reg-
ulator of HIF-1α protein stability (57).
Given that TGF-β promotes Tregs and Th17 cells, and the
decision between a Treg and a Th17 cell is influenced both by the
relative amount of TGF-β and by the presence of inflammatory
cytokines (e.g., IL-6 and IL-1 promote Th17 differentiation,
limiting Tregs) (58), we postulate that the overall inductive role
of hypoxia on T-cell differentiation will be an integration of HIF-
1α, TGF-β, and the surrounding cytokine environment. The use
of hypoxia and HIF-1α to enhance both Tregs and Th17 cells is
particularly fascinating given that both of these cell types play
integral parts in maintaining tissue homeostasis within the gut
(59, 60), a site that is characterized by hypoxia (both basally and
during inflammation) (1, 3).
On the basis of these insights, we postulate that HIF-1α is in-
volved in both Treg and Th17 differentiation. Indeed, the obser-
vation that Tregs may use a transcriptional regulator expressed in
proinflammatory T cells is well established in the literature: Tregs
use Stat3, a key transcription factor required for the generation of
Th17 cells, to limit Th17-mediated inflammation in the gastroin-
testinal tract (61), an observation made possible only through
genetic ablation of Stat3 specifically within Tregs. Beyond this
seminal study, Treg-intrinsic roles for transcriptional regulators
initially defined in effector CD4 T cells have now been observed
for multiple transcription factors, including IRF4, T-bet, Blimp-1,
GATA3, Bcl-6, and c-Rel (62–69). On the basis of this expanding
literature, we hypothesize that HIF-1α regulates multiple T-cell
fates; although some of these effects might be elicited by strong
metabolic demands (e.g., induced by robust proliferation or
inflammatory cytokines like IL-6 in the context of Th17 differen-
tiation), other effects might be elicited by unique microenviron-
mental cues (e.g., hypoxia driving Treg generation).
Taken together, our data indicate that oxygen availability can
function as a local cue that influences T-cell differentiation, with
a prominent outcome being enhanced Treg abundance through
HIF-1α–dependent regulation of FoxP3. Our data further in-
dicate that manipulating HIF signaling has the potential to limit
inflammation at both a local and a systemic level, offering unique
opportunities to shape the outcome of diseases characterized by
pathologic inflammation. Future challenges will include the
translation of our findings from studies in mice or in culture
systems of human immune cells into the treatment of patients.
However, it is of significance to point out that pharmacologic
strategies to induce HIF stabilization have recently been tested
in patients (15), thereby setting the stage to use PHD inhibitors
to treat patients suffering from inflammatory hypoxia, such as
occurs in the setting of inflammatory bowel disease.
Materials and Methods
Mice. C57BL/6J, B6.Rag1−/−, Hif1a-flox/flox, LckCre, ODD-luciferase, Foxp3-
GFP, and Ubc-GFP mice were obtained from Jackson Laboratory. Hif1a-flox/
flox × LckCre mice were F2 progeny of Hif1a-flox/flox and LckCre mice. All
experiments were approved by the Institutional Animal Care and Use
Committee of the University of Colorado Denver, in accordance with the
National Institutes of Health guidelines for use of live animals. The Univer-
sity of Colorado Denver, Anschutz Medical Campus is accredited by the
American Association for Accreditation of Laboratory Animal Care. Further
details are in SI Materials and Methods.
T-Cell Purification and Culture. T cells were purified by magnetic bead en-
richment and FACS, with naive CD4 T cells defined as CD62Lhigh CD44low. Bulk
splenocytes were stimulated with 1 μg/mL soluble anti-CD3ε (145-2C11;
eBioscience) or naive CD4 T cells were stimulated with anti-CD3/anti-CD28
microbeads (Dynabeads Mouse T-Activator CD3/CD28; Invitrogen) with 10
ng/mL IL-2, with analysis at day 3 poststimulation. In vitro Treg suppression
assays were done as described in ref. 70. Th17 differentiation used bulk
splenocytes cultured with soluble anti-CD3, IL-2 (10 ng/mL), TGF-β (5 ng/mL),
IL-6 (10 ng/mL), anti–IFN-γ (10 μg/mL; XMG1.2), and anti–IL-4 (10 μg/mL;
11B11). Further details are in SI Materials and Methods.
Luciferase Assays. Luciferase assays were done using standard luciferase (Dual
Luciferase Assay Kit; Promega) from plasmid-transfected Jurkat cells or
magnetically enriched CD4 T cells from ODD-luciferase mice (34) as detailed
in SI Materials and Methods.
Lentiviral HIF-1α Knockdown. Jurkat cells were subjected to lentiviral trans-
duction and selected for HIF-1α knockdown as detailed in SI Materials
and Methods.
Hypoxia and HIF Stabilization. Cells were subjected to hypoxia (1% O2) in
a humidified hypoxia chamber (Coy Laboratory Products) or treated with
PHD inhibitor AKB-6899 (100 μM). For in vivo hypoxia, mice were exposed to
hypobaric pressure (mimicking ∼10% atmospheric O2 by volume) or injected
with PHD inhibitor AKB-4924 (5 mg/kg, every day for 6 d) (kind gift of Robert
Shalwitz, Akebia Therapeutics, Cincinnati, OH). Further details are in SI
Materials and Methods.
RNA Isolation, Real-Time PCR, ChIP, and Primers. Total RNA was extracted by
TRIzol, followed by cDNA synthesis and quantitative real-time reverse-
transcriptase PCR (qPCR). ChIP assay was done using standard protocols.
Antibodies and primers are in SI Materials and Methods.
Antibodies and Flow Cytometric Analysis. Antibodies (eBioscience) and flow
cytometric analysis (LSR II with FACSDiva software; BD) were done using
standard protocols for detection of intracellular antigens as detailed in SI
Materials and Methods.
CD45RBhigh Colitis. To induce colitis, Rag1-deficient mice were adoptively
transferred with a 1:4 ratio of Tregs:CD45RBhigh CD4 T cells, using control or
Hif1a-deficient CD4+ CD25+ Tregs. Mice were weighed weekly, with tissues
analyzed for colitis at harvest. Further details are in SI Materials
and Methods.
Data Analysis. Analysis was done using Prism 4.0c (GraphPad Software),
FlowJo (TreeStar), or MacVector. Statistical analyses were performed by
unpaired t tests or one-way ANOVA and posttest Tukey’s correction as in-
dicated. Further details are in SI Materials and Methods.
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